Jun 23, 2022 | Cancer Center News
MYC promotes POLR3G gene expression, shaping Pol III identity and downstream transcription activities associated with cell proliferation. Urbana, Ill. – Researchers at the University of Illinois Urbana-Champaign and Stanford University School of Medicine have...
Mar 30, 2022 | Cancer Center News
Shannon Sirk and the Sirk Research Group. Urbana, Ill. – An Illinois research team is developing a method of producing and delivering monoclonal antibody treatments for breast cancer through commensal microbes in the gut. If successful, this approach could increase...
Feb 7, 2022 | Cancer Center News
Image of Rohit Bhargava in lab. Illinois Innovators Podcast: Cancer and Engineering with Rohit Bhargava Click here to listen Urbana, Ill. – In March 2005, Professor Rohit Bhargava was the first external hire to join the Department of Bioengineering as it launched. Now...
Oct 20, 2021 | Cancer Center News
Photo of Shannon Sirk. Urbana, Ill. – Therapeutic antibodies have revolutionized the treatment of many diseases, including cancer. However, these drugs can be prohibitively expensive and are not an option for every patient. Shannon Sirk, Cancer Center at Illinois...
Jul 27, 2021 | Cancer Center News
Urbana, Ill. – As a Johnson & Johnson 2021 WISTEM2D Scholar Award winner, chemistry professor Hee-Sun Han will be developing a new imaging-based methodology to study RNA-RNA interactions in breast cancer. Each year, the company selects six world-leading female...
Jul 21, 2021 | Cancer Center News
Illinois researchers on the study include, from front left, research scientist Chengjian Mao and graduate students Matthew Boudreau, Darjan Duraki and Ji Eun Kim. In the back row, from left, are molecular and integrative physiology professor Erik Nelson, chemistry...
Jun 10, 2021 | Cancer Center News
Harpal Singh, BioengineeringCancer Scholar, 2017 Cohort Where are you working now? I am a senior about to graduate this May. Following graduation, I will be working in a Biologics rotational program with the company Catalent Pharma. What are you currently researching?...
May 4, 2021 | Cancer Center News
Urbana, Ill. – A team from the University of Illinois Urbana-Champaign’s Grainger College of Engineering and Mayo Clinic have developed a new technique for creating “microcancer” cell cultures. It allows researchers to form hundreds of microcancers in a...
May 1, 2021 | Cancer Center News
Project title: “Deep Mutational Scanning of Receptor Tyrosine Kinases Involved in Cancer Using Transfer Learning Approaches” Research team includes: Erik Procko, assistant professor in biochemistry What led to your exploration of cancer? Cancer is one of...
Feb 23, 2021 | Cancer Center News
Left – Individual cells invade away from a central tumor spheroid and into the surrounding vascularized microenvironment. Tumor cells are shown in red and vasculature is shown in green. Right – Individual tumor cells (red) interact closely with surrounding vasculature...
Nov 10, 2020 | Cancer Center News
Current cancer treatments include drugs that target standard protein synthesis in cells, which can kill cancer cells, but also targets healthy cells. To address this issue, Cancer Center at Illinois (CCIL) member and professor of biophysics and quantitative biology,...
Nov 3, 2020 | Cancer Center News
Although small molecule drugs and antibodies continue to be the standard for cancer treatment, a new class of therapeutics — lasso peptides — may prove effective, especially for disease targets that thwart traditional approaches. Combining the power of antibodies and...
